Re:Wegovy and Ozempic (semaglutide) associated with reductio...
by hnburnsy on Monday June 03, 2024 @02:54PM
(#40566115)
Government could build their own plants, these drugs are not under patent, just the drug+delivery mechanism is. This says $5 per month as actual costs.
https://www.healthline.com/health-news/how-affordable-could-...
Re:Wegovy and Ozempic (semaglutide) associated with reductio...
by JumpCrisscross on Monday June 03, 2024 @02:57PM
(#40566135)
> these drugs are not under patent
"Semaglutide is expected to become patent-free in the United States no earlier than December 2031" [1].
We could probably strike a volume deal for ~$200 for 5 years and then $75 (the upper end of your study’s estimate for manufacturing cost) for another 5.
Re:Wegovy and Ozempic (semaglutide) associated with reductio...
by hnburnsy on Monday June 03, 2024 @03:30PM
(#40566565)
https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-...
My understanding is that they are patentening the drug+device and or the dosing, not the molecule. Looks like the FTC is clamping down on it.
To put that into perspective, annual cost of diabetes to America is $1,200 per capita ($1,300 adjusted for inflation [2]. 40% more than a month of Ozempic [3].
One twelfth of Americans have diabetes [4]. If the government could negotiate just a 10% bulk discount, the payback period on buying every American with diabetes Ozempic would be around a year. Even if everyone ceased treatment after that, even if you only did this for a couple years, we'd see a permanent boost in productivity and health across the American population.
[1] https://pubmed.ncbi.nlm.nih.gov/37909353/
[2] https://www.usinflationcalculator.com
[3] https://ro.co/weight-loss/ozempic-cost-without-insurance/
[4] https://www.niddk.nih.gov/health-information/health-statisti...